M. Sc, CEO.
Andreas Gerward
Andreas has during the last 7 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
andreas.gerward@stayble.se +46 (0)730 808 397Below is an overview of the Company’s largest owners as of 31 March 2021
| Name | Total shares | Percentage |
|---|---|---|
| Stiftelsen Chalmers Tekniska Högskola | 1 542 000 | 11,1% |
| Avanza Pension | 1 021 608 | 7,4% |
| ALMI Invest Västsverige AB | 924 349 | 6,7% |
| Nordnet Pension | 896 058 | 6,5% |
| Robert Joki | 886 340 | 6,4% |
| Kjell Olmarker | 700 000 | 5,0% |
| Futur Pension | 595 000 | 4,3% |
| K-Svets Venture AB | 382 880 | 2,8% |
| Andreas Gerward | 345 000 | 2,3% |
| Advecto AB | 262 400 | 1,9% |
